Association of the apolipoprotein E ε4 allele with late-onset depression

Neuroepidemiology

Volumn 20, Issue 4, 2001, Pages 268-272

  Rigaud, Anne Sophie ^a   Traykov, Latchezar ^b   Caputo, Ludovica ^e   Coste, Joël ^c   Latour, Florence ^a   Couderc, Rémy ^d   Moulin, Florence ^a   Boller, François ^b   Forette, Françoise ^a  

^a Paris Descartes University   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

^d HÔPITAL TENON   (France)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Late life depression; Late onset depression

Indexed keywords

APOLIPOPROTEIN E4; PROTEIN SUBUNIT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; RISK; RISK FACTOR;

AGE OF ONSET; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS;

EID: 0035742183     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054801     Document Type: Article

References (44)

1. Depression in patients referred to a dementia clinic: A three-year prospective study
2. The course of geriatric depression with reversible dementia: A controlled study
3. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community
4. Criteria for diagnosing reversible dementia caused by depression: Validation by 2-year follow-up
5. The prognosis of depression in old age
6. A comparison of early-onset and late-onset depressive illness in the elderly
7. Gene dose of apolipoprotein E Type 4 allele and the risk of Alzheimer's disease in late onset families
8. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
9. Apolipoprotein E-ε4 frequency in geriatric depression
10. Apolipoprotein E: Depressive illness, depressive symptoms and Alzheimer's disease
11. Apolipoprotein E phenotype is not related to late-life depression in a population-based sample
12. Early-onset and late-onset depression are independent of the genetic polymorphism of apolipoprotein E
13. Development and validation of a geriatric depression screening scale: A preliminary report
14. 'Mini-Mental Test'. A practical method for grading the cognitive state of patients for the clinician
15. The cognitive efficiency profile: Description and validation in patients with Alzheimer disease
16. Profil cognitif des plus âgés
17. Brain computed tomography findings in geriatric depression and primary degenerative dementia
18. Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease
19. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
20. Direct phenotyping of human apolipoprotein E in plasma: Application to population frequency distribution in Paris (France)
21. Association of the ApoE ε4 allele with clinical subtypes of late life depression
22. The course of depression in the elderly: A longitudinal community-based study in Australia
23. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+
24. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults
25. A twin study of late-onset depression and apolipoprotein Eε4 as risk factors for Alzheimer's disease
26. Clinically defined vascular depression
27. MRI-defined vascular depression
28. Hypertension and DSM-III depression in psychiatric outpatients
29. Major depressive disorder in coronary artery disease
30. MRI signal hyperintensities in geriatric depression
31. Cognition and white matter hyperintensities in older depressed patients
32. Magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease
33. Long-term follow-up of depressive pseudodementia of the aged
34. Regional cerebral glucose metabolism in late-life depression and Alzheimer's disease: A preliminary positron emission tomography study
35. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease
36. Apolipoprotein-E genotype and Alzheimer's disease
37. ApoE-ε4 in patients with Alzheimer's disease and vascular dementia
38. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia
39. Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients
40. Apolipoprotein E allele frequencies in demented and cognitively impaired patients with and without cerebrovascular disease
41. Apolipoprotein-E genotype influences amyloid deposition and limbic neurofibrillary degeneration, but not Lewy body or vascular pathologies in postmortem brains
42. Cardiovascular factors in Alzheimer's disease